Retrospective Study
Copyright ©The Author(s) 2022.
World J Hepatol. Sep 27, 2022; 14(9): 1804-1816
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1804
Table 3 Univariate and multivariate analyses of clinical risk factors associated with liver cancer
Variables
Univariate analysis
Multivariate analysis

Unadjusted odds ratio1 (95%CI)
P value
Adjusted odds ratio2 (95%CI)
P value
Hereditary hemochromatosis (without cirrhosis)10.887 (4.376-27.087)< 0.000128.838 (10.387-80.068)< 0.0001
Alcoholic cirrhosis14.398 (13.701-15.131)< 0.000116.881 (15.949-17.868)< 0.0001
Non-alcoholic cirrhosis33.241 (31.732-34.822)< 0.000117.446 (16.507-18.439)< 0.0001
Biliary cirrhosis12.278 (8.858-17.019)< 0.000119.245 (13.439-27.557)< 0.0001
NASH/NAFLD7.393 (6.982-7.828)< 0.00012.955 (2.732-3.196)< 0.0001
Hepatitis B16.711 (15.149-18.434)< 0.000112.145 (10.848-13.597)< 0.0001
Hepatitis C19.488 (18.798-20.203)< 0.00018.576 (8.195-8.975)< 0.0001
Other viral hepatitis2.978 (2.762-3.211)< 0.00011.357 (1.216-1.514)< 0.0001
HIV1.666 (1.537-1.807)< 0.00010.649 (0.571-0.737)< 0.0001
Obesity0.571 (0.556-0.587)< 0.00010.614 (0.590-0.640)< 0.0001
Diabetes mellitus with chronic complications0.845 (0.825-0.866)< 0.00010.855 (0.824-0.887)< 0.0001
Diabetes mellitus without chronic complications1.168 (1.145-1.192)< 0.00011.168 (1.132-1.205)< 0.0001
Hypertension0.792 (0.779-0.806)< 0.00010.850 (0.828-0.872)< 0.0001
Blood transfusion2.356 (2.255-2.463)< 0.00011.801 (1.689-1.919)< 0.0001
Alpha1-antitrypsin deficiency3.912 (2.669-5.735)< 0.00012.100 (1.210-3.643)0.0087
Disorders of porphyrin metabolism5.145 (2.902-9.120)< 0.00012.428 (1.163-5.066)0.0187
Wilson disease4.099 (1.800-9.332)0.00084.269 (1.182-15.414)0.0279
Smoking1.204 (1.184-1.225)< 0.00010.874 (0.851-0.897)< 0.0001
opioids1.412 (1.338-1.490)< 0.00010.687 (0.631-0.749)< 0.0001